Lupin launches Varenicline Tablets

10 Jan 2024 Evaluate

Lupin has launched Varenicline Tablets, 0.5 mg and 1 mg, after having received an approval from the United States Food and Drug Administration (USFDA).

Varenicline Tablets, 0.5 mg and 1 mg is the generic equivalent of Chantix Tablets, 0.5 mg and 1 mg, of PF Prism C.V. It is indicated for use as an aid to smoking cessation treatment. Varenicline Tablets (RLD Chantix) had estimated annual sales of $412 million in the U.S. (IQVIA MAT November 2023). 

Lupin is an innovation led transnational pharmaceutical company producing, developing and marketing a wide range of branded and generic formulations, biotechnology products and active pharmaceutical ingredients (APIs) globally.


Lupin Share Price

1658.15 -1.80 (-0.11%)
21-May-2024 11:40 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1532.15
Dr. Reddys Lab 5790.50
Cipla 1419.10
Zydus Lifesciences 1109.95
Lupin 1658.15
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.